Discovery of Sirolimus Sensitive Biomarkers in Blood
Clinical trial NCT03304678 · COMPLETED
Trial details
- NCT number
- NCT03304678
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-04
- Primary completion
- 2025-03-09
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.